Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 21, 2017; 23(35): 6412-6419
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412
Table 1 Body weight in each group at wk 8, 10 and 12
Group
Body weighting
8 wk10 wk12 wk
Healthy control group, A510536527
TAA group, B394401454
TAA + low-dose aspirin group, C381403403
TAA + high-dose aspirin group, D381364408
TAA + enoxaparin group, E385409415
Table 2 Changes in alanine aminotransferase, albumin, total bilirubin, prothrombin time and International normalized ratio in each group
GroupWkALTALBTBILPTINR
Healthy control group, A83529.12.959.2-
1041.030.12.38.80.83
1240.0302.89.30.88
TAA group, B845.0293.49.40.78
1049.5293.49.40.89
1260.028.54.210.30.97
TAA + low-dose aspirin group, C1048.029.62.210.20.96
1254.528.54.410.50.99
TAA + high-dose aspirin group, D1060.529.73.59.450.895
1247.029.254.7510.10.950
TAA + enoxaparin group, E1045.0303.49.450.895
1247.028.74.810.20.96
Table 3 Staging and scoring of liver fibrosis in each group at wk 12
Group
n
Liver fibrosis stage
Liver fibrosis score
F0F1F2F3F4
Healthy control group, A5500000
TAA group, B700214b4
TAA + low-dose aspirin group, C901530bce2
TAA + high-dose aspirin group, D806011bc1
TAA + enoxaparin group, E800530 bce2